Mohamed I F Shariff

Summary

Affiliation: Imperial College
Country: UK

Publications

  1. ncbi Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics
    Mohamed I F Shariff
    Liver Unit, Faculty of Medicine, Imperial College London, St Mary s Hospital, 10th Floor QEQM Building, South Wharf Road, London W2 1NY, UK
    Expert Rev Gastroenterol Hepatol 3:353-67. 2009
  2. ncbi Characterization of urinary biomarkers of hepatocellular carcinoma using magnetic resonance spectroscopy in a Nigerian population
    Mohamed I F Shariff
    Liver Unit, Department of Medicine, Imperial College London, QEQM Building, St Mary s Hospital Campus, South Wharf Road, London W2 1NY, United Kingdom
    J Proteome Res 9:1096-103. 2010
  3. ncbi Urinary metabolic biomarkers of hepatocellular carcinoma in an Egyptian population: a validation study
    Mohamed I F Shariff
    Liver Unit, Division of Diabetes Endocrinology and Metabolism, Department of Medicine, Imperial College London, 10th Floor QEQM Building, St Mary s Hospital Campus, South Wharf Road, London W2 1NY, United Kingdom
    J Proteome Res 10:1828-36. 2011
  4. ncbi Hepatocellular carcinoma: diagnostics and screening
    Madhvi Patel
    Division of Diabetes Endocrinology and Metabolism, Department of Medicine, Imperial College London, London, UK
    J Eval Clin Pract 18:335-42. 2012
  5. ncbi Biofluid metabonomics using (1)H NMR spectroscopy: the road to biomarker discovery in gastroenterology and hepatology
    Neeral R Patel
    Liver Unit, Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, 10th Floor, QEQM Wing, St Mary s Hospital Campus, Imperial College London, South Wharf Street, London, W2 1NY, UK
    Expert Rev Gastroenterol Hepatol 6:239-51. 2012

Collaborators

Detail Information

Publications5

  1. ncbi Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics
    Mohamed I F Shariff
    Liver Unit, Faculty of Medicine, Imperial College London, St Mary s Hospital, 10th Floor QEQM Building, South Wharf Road, London W2 1NY, UK
    Expert Rev Gastroenterol Hepatol 3:353-67. 2009
    ..This review outlines the epidemiological trends, risk factors, diagnostic developments and novel therapeutics for HCC, both in the developing and developed world...
  2. ncbi Characterization of urinary biomarkers of hepatocellular carcinoma using magnetic resonance spectroscopy in a Nigerian population
    Mohamed I F Shariff
    Liver Unit, Department of Medicine, Imperial College London, QEQM Building, St Mary s Hospital Campus, South Wharf Road, London W2 1NY, United Kingdom
    J Proteome Res 9:1096-103. 2010
    ..These findings have identified candidate urinary HCC biomarkers which have potential to be developed as simple urinary screening tests for the clinic...
  3. ncbi Urinary metabolic biomarkers of hepatocellular carcinoma in an Egyptian population: a validation study
    Mohamed I F Shariff
    Liver Unit, Division of Diabetes Endocrinology and Metabolism, Department of Medicine, Imperial College London, 10th Floor QEQM Building, St Mary s Hospital Campus, South Wharf Road, London W2 1NY, United Kingdom
    J Proteome Res 10:1828-36. 2011
    ....
  4. ncbi Hepatocellular carcinoma: diagnostics and screening
    Madhvi Patel
    Division of Diabetes Endocrinology and Metabolism, Department of Medicine, Imperial College London, London, UK
    J Eval Clin Pract 18:335-42. 2012
    ..This review outlines the epidemiological trends and risk factors for HCC; diagnostic techniques and current guidelines for screening and surveillance; and newer methods of screening...
  5. ncbi Biofluid metabonomics using (1)H NMR spectroscopy: the road to biomarker discovery in gastroenterology and hepatology
    Neeral R Patel
    Liver Unit, Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, 10th Floor, QEQM Wing, St Mary s Hospital Campus, Imperial College London, South Wharf Street, London, W2 1NY, UK
    Expert Rev Gastroenterol Hepatol 6:239-51. 2012
    ..This technique-driven review aims to demystify the metabonomics pathway, while also illustrating the potential of this technique with recent examples of its application in hepato-gastroenterological disease...